Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World ADHD study seeks to personalize care for kids

NCT ID NCT07273695

Knowledge-focused Sponsor: IRCCS Eugenio Medea Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watches 80 children (ages 8-15) with ADHD and emotional or behavioral problems to see how standard treatments like medication and group therapy affect their symptoms. Researchers compare treated kids to those on a waiting list, using questionnaires, computer tests, and brain scans. The goal is to find which treatments work best for which child, leading to more personalized care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with symptoms of emotional-behavioral dysregulation, externalizing disorders, and/or ADHD will be recruited. The presence of these symptoms and diagnoses must be assessed prior to entry into the research project by experienced clinicians through clinical interviews and questionnaires. Children and adolescents aged 8-15 will be recruited. For psychotherapeutic treatment, participants will be divided into separate groups based on age and skills: 8-11 and 12-15. Patients with an IQ greater than 75 will be recruited, and, for the psychotherapeutic treatment group, those with good mentalization skills. Pharmacological intervention will be proposed in indicated cases following international guidelines (for example, for ADHD, treatment with methylphenidate is administered in cases of Clinical Global Index severity (CGI-S) ≥ 4). A control group will be recruited consisting of patients on the waiting list for treatment, with the same diagnoses and comparable age.

Ages

8 to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Children and adolescents aged 8-15 years; * Diagnosis of externalizing disorder, ADHD, and/or emotional dysregulation (assessed with questionnaires, interviews, and/or clinical observation); * Intelligence quotient ≥ 75. Exclusion Criteria * IQ \< 75; * Substance abuse and addictions; * Psychosis; * Acute disorders; * Organic brain disorders; * Presence of neurological diseases, epilepsy; * Genetic syndromes; * Co-diagnosis with other psychiatric or neurodevelopmental disorders (e.g., autism, anxiety, depression, etc.) and prior psychopharmacological therapy will not be considered exclusion criteria but will be recorded and declared.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit hyerpactivity disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder Behavior conduct disorder disruptive behavior disorder oppositional defiant disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention deficit hyerpactivity disorder Conduct disorder Disruptive behaviours Emotional dysregulation Externalizing problems Oppositional defiant

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • IRCCS E Medea Scientific Institute - Asssociazione La Nostra Famiglia

    RECRUITING

    Bosisio Parini, Lecco, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.